Dr. Hans Loibner

Advisor (Science & Strategy), Founder

PhD in Organic Chemistry (University of Vienna, Austria)

40 years of professional experience in R&D management, development of medicinal products at Sandoz/Novartis and Chief Executive Officer (CEO) of innovative and successful biotech companies (Igeneon, Apeiron)

Successful commercial development of a therapeutic antibody for treatment of a life-threatening orphan pediatric disease

Strong focus on targeted development and company strategy since 1985

Prof. Dr. Holger Lode

Advisor (Clinical Development), Founder

MD in Pediatric Medicine (University of Tuebingen, Germany)

Over 25 years of professional experience in pediatric hematology and oncology, in tumor immunology and immuno-oncology

Chair of the Department of General Pediatrics and Pediatric Hematology and Oncology at the University Medicine Greifswald

Sponsor and principal investigator of pivotal clinical trials for commercialization of therapeutic antibodies


Dr. Wolfgang Stoiber

Advisor (Business & Financing), Founder

MD and MBA (University of Munich, Germany and University of Pennsylvania, USA)

Over 30 years of experience as a physician, pharmaceutical industry executive, and investment banker

Partner at JSB-Partners. Advised numerous companies, closing transactions with a cumulative value of more than $2.5 billion. Previously at MPM Capital and Hoffmann-LaRoche

Served on the board of directors of several pharmaceutical and biotech companies

Dr. Ulrich Granzer

Advisor (Regulatory & Development Strategy)

PhD in Pharmacy (University of Marburg)

Over 30 years of professional experience in global regulatory affairs and development strategy of medicinal products and medical devices

Founder and owner of Granzer Regulatory Consulting & Services
Proven track record to successfully accompanying a significant number of medicines to commercial approval in EU, US and other key regions

Member of the supervisory board of several pharmaceutical and biotech companies